Items where Author is "Saba, J"

Journal article

MCARDLE, S.E., REES, R.C., MULCAHY, K.A., SABA, J., MCINTYRE, C.A. and MURRAY, A.K., 2000. Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant. Cancer Immunology Immunotherapy, 49 (8), pp. 417-425. ISSN 0340-7004

MCARDLE, S.E., REES, R.C., MULCAHY, K.A., SABA, J., MCINTYRE, C.A. and MURRAY, A.K., 2000. p53 conformational mutants are killed preferentially by cytotoxic T lymphocytes generated in vitro using dendritic cells pulsed with new wild-type p53 peptide. Cancer Immunology Immunotherapy, 49 (8).

MURRAY, A.K., MCARDLE, S.E., SABA, J., MULCAHY, K.A., MCINTYRE, C.A. and REES, R.C., 1998. Generation of cytotoxic T lymphocytes in vitro using wild-type p53 peptide-pulsed dendritic cells. Journal of Leukocyte Biology, p. 97. ISSN 0741-5400

SABA, J., MCINTYRE, C.A., REES, R.C. and MURRAY, A.K., 1997. Recognition of melanoma-associated peptides by peripheral blood mononuclear cells of ocular melanoma patients. Cancer Gene Therapy, 4 (5), p. 313. ISSN 0929-1903

Chapter in book

SABA, J., MCINTYRE, C.A., REES, R.C. and MURRAY, A.K., 1998. Recognition of melanoma-associated peptides by peripheral blood mononuclear cells of ocular melanoma patients. In: P. WALDEN, U. TREFZER, W. STERRY, F. FARZANEH and P. ZAMBON, eds., Gene therapy of cancer. Boston, MA: Springer. ISBN 9781461374442